Global Longlife Hospital (GLHRL) Q2 FY27 Posts Profit on Zero Operating Revenue
The company reported a nominal profit of ₹0.02 crore for Q2 FY27, driven entirely by other income, as its hospital business remains wound down.
Global Longlife Hospital reported a small profit of ₹0.02 crore for Q2 FY27 despite zero operating revenue. The result was supported by other income as the company finalizes its rebranding to Asahi Enterprise and pivots away from healthcare.
Global Longlife Hospital and Research is no longer a hospital in any meaningful sense. Its second-quarter results confirm a complete operational shutdown, with the nominal profit stemming from incidental income as the company executes a fundamental reinvention.
The numbers tell a story of transition. For the quarter ended September 2026, revenue from operations was zero, continuing a trend from the prior year. A small profit of ₹0.02 crore was recorded, a sequential improvement from a ₹0.4 crore loss last quarter. This profit was entirely due to other income of ₹0.57 crore, which covered total expenses of ₹0.54 crore.
Revenue & profit
Revenue (₹ Cr)
Profit (₹ Cr)
| Metric | CurrentQ2 FY27 | Same quarter LYQ2 FY26 |
|---|---|---|
| Period | Sep 2026 | Sep 2025 |
| Revenue (₹ Cr) | 0.00 | 0.00 |
| Profit (₹ Cr) | 0.02YoY +102% | -1.32 |
The table shows the stark decline from a functioning business two years ago to a corporate shell today. According to analysis by newboard.in, the company's Ahmedabad hospital has wound down, its office moved, and it had just three permanent employees as of March 2026.
A Pivot from Pills to Produce
The company is not looking back. It has received regulatory approval to change its name to Asahi Enterprise Limited, effective September 2026. Its new memorandum of association, as reported by stockwatch.live, expands its business scope to trading food grains, textiles, and bullion.
This explains the lack of hospital-related capex or reopening plans. Management has provided no guidance on resuming healthcare operations, focusing instead on procedural compliance for the rebranding. A StockFin.ai analysis notes the absence of strategic commentary creates uncertainty about the new trading venture's launch timeline.
The Financial Shell Game
With zero debt and a current ratio over 1,600, the balance sheet is liquid but idle. Investing.com data indicates a cash balance of roughly ₹17 crore as of the last report. This war chest, alongside a shrinking asset base, suggests the company is preserved for its new incarnation rather than its old one.
The stock rose nearly 5% following the results announcement, as per FYERS data. This muted positive reaction likely reflects relief at avoiding another loss rather than optimism for the hospital business. Promoter holding has halved over the past year, while retail ownership has risen above 56%.
Key Points
- Global Longlife Hospital reported a ₹0.02 crore profit for Q2 FY27 on zero operating revenue, with the profit entirely supported by other income.
- The company has legally changed its name to Asahi Enterprise Limited and plans to pivot into trading agricultural commodities and textiles.
- Its former hospital business in Ahmedabad is wound down, with no disclosed plans for resumption or related capital expenditure.
- The balance sheet remains debt-free with significant cash, but promoter stake has fallen sharply as ownership shifts to retail investors.
Hexa Perspective
This quarter underscores a corporate identity crisis resolved on paper but not yet in practice. The numbers reflect a company between lives: the hospital is closed, but the new trading entity exists only in regulatory filings.
The path forward hinges entirely on executing the pivot into commodities trading, a field with its own competitive and cyclical risks. Until revenue materializes from the new business, the company remains a cash-rich shell with an uncertain operating future, its valuation disconnected from any current earnings power.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.
